Venous Thrombosis
📧 Sign up to get email alerts when something new happens for Venous Thrombosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-25EMA Authorised: Svariya (previously Rivaroxaban Koanaa) (rivaroxaban) — Koanaa Healthcare GmbH
EMA authorised Svariya (rivaroxaban) for prevention and treatment uses related to thromboembolic conditions; managed by Koanaa Healthcare Gm…
-
EMA approval · 2026-08-18EMA Authorised: Arixtra (fondaparinux sodium) — Viatris Healthcare Limited
The EMA authorised Arixtra (fondaparinux sodium) for venous thrombosis, pulmonary embolism, myocardial infarction, and unstable angina, unde…
-
EMA approval · 2026-01-29EMA Authorised: Arixtra (fondaparinux sodium) — Viatris Healthcare Limited
The EMA authorised Arixtra (fondaparinux sodium) by Viatris Healthcare Limited for thromboembolic conditions including venous thrombosis, pu…
-
EMA approval · 2025-12-17EMA Authorised: Rivaroxaban Koanaa (rivaroxaban) — Koanaa Healthcare GmbH
The European Medicines Agency authorised Koanaa Healthcare GmbH's rivaroxaban product, Koanaa, for indications including venous thromboembol…